BackAcrivon Therapeutics Overview

Acrivon Therapeutics Current Cash

Latest current cash for ACRV: $34M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$34.06M
↓ 13.00% YoYΔ $-5.09M vs prior year quarter

Peer average / median

Loading

Acrivon Therapeutics Current Cash History

Loading

Acrivon Therapeutics vs. peers: Current Cash Comparison

Loading

Acrivon Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acrivon Therapeutics (ACRV) FAQ

Acrivon Therapeutics (ACRV) currently reports a current cash of $34M as of March 2026. That compares with $39M in the prior-year period — down 13.0% year over year. Use the charts on this page to explore Acrivon Therapeutics's current cash history and peer comparisons.

Acrivon Therapeutics's current cash decreased from $39M to $34M — a 13.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acrivon Therapeutics reported $34M in current cash as of March 2026. That compares with $39M in the prior-year period — down 13.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acrivon Therapeutics, and consider following ACRV for alerts when major investors trade the stock.